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Abstract

We have developed a statistical method for the analysis of array based CGH data
to detect genomic DNA copy number changes. Our method allows us to answer
the biologically relevant questions (what is the probability that a given gene or
region has increased or decreased copy number changes) in a clear and simple
way, within a rigorous statistical framework. We use a non-homogeneous Hidden
Markov Model that incorporates distance between genes, a crucial requirement to
analyze data from platforms where distances between probes is highly variable.
As the true number of hidden states (states of copy number changes) is not known
in advance in biological samples, we do not fix the number of hidden states of the
model, but use Reversible Jump Markov Chain Monte Carlo for inference. We
can therefore investigate the likely number of hidden states in the data and, more
importantly, provide posterior probabilities that a gene or a set of genes is in a
given state. To summarize results, we employ Bayesian Model Averaging, averaging over models with different states, and thus incorporating model uncertainty.
Our method can be used to analyze data from each chromosome independently or
all chromosomes together, offering both flexibility in the biological phenomena
studied and increased statistical precision. Thus, our method provides a rigorous
statistical foundation for locating genes and chromosomal regions with altered
copy number and potentially related to cancer and other complex diseases.
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Abstract
Genomic DNA copy number changes are associated with the development of complex diseases, and their detection from aCGH data has allowed the identification of genes relevant for
disease progression and as therapeutic targets [PA05, LCCL06]. Several methods are available
for aCGH data analysis, but they suffer from shortcomings that limit their applicability. We
have developed a method, RJaCGH, for locating genes and chromosomal regions with altered
copy number from aCGH data. Main features of RJaCGH are: a) it provides a direct answer
to the question of the probability that a gene or region has altered copy number; b) it incorporates, in the analysis, the distance between genes, a requirement when using data from platforms with highly variable inter-gene distance [MTT06, FSPA04, LJKP05, BR06, HWLZ05]; c)
it can analyze data from each chromosome independently or from all chromosomes together,
focusing on two different biological phenomena (gains/losses of loci within chromosome vs.
chromosomal gains/losses) [SXD+ 06, BR06, EMLB06]; d) it outperforms alternative methods, an advantage that increases as inter-gene distance variability and data noise increase.
This probabilistic framework will be crucial for adaptable definitions of minimal common regions of gain/loss of genomic material among samples and the incorporation of expression
data.

1

Introduction

The relationship between gains and losses of genomic DNA and several hereditary anomalies and
human cancers [PA05, LCCL06] highlights the need for accurate detection of genomic DNA copy
number changes. In cancer, for instance, copy number alterations have been associated with
tumoral grade, metastasis development, and patient survival, and studies about copy number
changes have been instrumental for identifying relevant genes for cancer development and patient
classification [PA05, LCCL06]. Array-based Comparative Genomic Hybridization (aCGH) is a
commonly used technique to identify copy number changes: two DNA samples (e.g., problem
and control) are differentially labeled and hybridized to chromosomal DNA targets and, after
hybridization, emission from the two fluorescent dyes is measured [PA05, LCCL06]. A key step in
aCGH is the analysis of the fluorescence ratio data to identify genes and contiguous chromosomal
regions with altered copy numbers.
The main biomedical problem, both for the study of the copy number alterations per se and
for downstream analysis (e.g., relationship with gene expression changes or patient classification),
is the accurate identification of the genes/chromosomal regions that have an altered copy number.
Satisfactorily dealing with this problem requires a method that: a) provides direct answers that
can be used in different settings (e.g., clinical vs. basic research); b) reflects the underlying biology
and accounts for key features of the technological platform; c) can accommodate the different levels
of analysis (types of questions) addressed with these data.
First, estimates of the probabilities of alteration (instead of p-values or smoothed means) are
the most direct and usable answer to this problem [EMLB06, BR06]. Probabilities can be used
1
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in contexts that cover from basic research to clinical applications [PA05, LCCL06] so that, for
instance, a clinician might require high certainty of alteration of a specific gene before more invasive
procedures, whereas a basic researcher can consider for further study genes that show only moderate
probability of alteration (e.g., probability > 0.5). Finally, appropriately used, probabilities of
alteration can account for uncertainty in model building [SXD+ 06, HMRV99].
Second, the analysis should incorporate distance between probes [MTT06, FSPA04, LJKP05,
BR06, HWLZ05, LCCL06]: widely used aCGH platforms like those based on cDNA microarrays
and ROMA lead to variable coverage across chromosomes, with very unequal distances between
probes (i.e., some regions have probes that are very close to each other, whereas in other regions
probes are very far apart). As copy number changes involve chromosome segments, contiguous
loci will have the same copy number, unless there is an abrupt change to another copy number
[PA05, DRO+ 04]: the further apart two loci are, the more likely it is that a copy number event will
have taken place in between them. Thus, in densely covered regions the copy number of a probe
is a good predictor of the copy number of the neighboring probes. In contrast, in poorly covered
regions, contiguous probes or loci might be many thousands of kilobases apart, making it more
likely that at least one copy number change has taken place, and consequently a probe provides less
information about the likely state of its neighboring probes. Therefore, unless we use a platform
where all probes are equally spaced, we need to use the distance between probes (and not just the
order), so that the information that consecutive probes provide is adequately accounted for.
Third, depending on the focus of the study, the analysis should be conducted either chromosome
by chromosome, or genome-wide [SXD+ 06, BR06, EMLB06]. Analysis at the chromosome level
are appropriate to detect alterations in copy number of loci relative to the rest of the loci in that
same chromosome, regardless of that chromosome’s ploidy (a trivial example would be detection
of copy number changes in loci of the human Y chromosome in an otherwise diploid genome). On
the other hand, detection of copy number changes that affect most of a chromosome often require
genome-wide analysis (in chromosome-wide analysis, as the mean or median chromosome level is
used as the reference, detection of such changes is virtually impossible). Moreover, the use of
genome-wide analysis can offer statistical advantages (e.g., reduced variance of estimation). As
both types of analysis offer complementary information, because they focus on different biological
phenomena (chromosomal gains/losses vs. gains of loci within chromosome), a suitable method
should allow these two approaches.

1.1

Previous work

Available methods for the analysis of aCGH fail some or most of these requirements. Smoothing
techniques [HST+ 04, OVLW04, PRM+ 05, HSG+ 05, LBL+ 05, HWLZ05, PRL+ 05] do not use gene
distance nor provide posterior estimates of the likely state of each gene/clone, and data from
each chromosome are analyzed independently of each other. Hidden Markov Models (HMMs)
and related techniques offer a flexible modeling framework, that can even provide probabilities of
alteration [EMLB06, SXD+ 06, BR06]. Some HMM-based models [FSPA04, SXD+ 06], however,
do not incorporate distance between genes, assuming instead that inter-gene distance is constant.
In addition, most of them do not deal satisfactorily with the unknown number of hidden states
(the true number of states of copy number). Some methods fix in advance the number of hidden
states (three [BR06, EMLB06] or four [SXD+ 06]): pre-specification of the number of states has
the consequence of jumbling all changes involving multiple gains into a single state with a common
mean, which is biologically questionable [DRO+ 04], specially as the resolution of the technology
improves. A better approach would provide posterior probabilities of the number of states; using
such a procedure over many different experiments will tell us whether three- or four-state models
are a reasonable simplification. Of those methods that do not assume a fixed number of hidden
states [FSPA04, MTT06, DRO+ 04], one [DRO+ 04] of them cannot be used for questions about the
number of hidden states, or for breaking the data into more categories than gained/lost/no-change,
which are increasingly important questions with higher-resolution techniques and are needed for
distinguishing regions of moderate copy gains from regions of large copy gains. The remaining
two [FSPA04, MTT06] examine HMMs for a range of number of states and then use AIC-based
model selection, but AIC-based selection with HMMs has not been theoretically justified [CMR05],
does not provide a probability of the likely number of states, and selecting a single model leads
to underestimation of the true variability in the data; these two methods, in addition, use a final
clustering step of hidden states that introduces several ad-hoc decisions.
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Model: overview
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We have developed a method, RJaCGH, that fulfills the three requirements above, and does not
suffer from the limitations discussed for other methods. We start our modeling by noting that,
for a given chromosome or genome, the copy numbers of genomic DNA (e.g., 0, 1, 2 copies, . . .)
of different genes or segments are an unknown finite number. Thus, genes or segments could
be classified into several groups with respect to their (unknown) copy number. In addition, as
mentioned above, we expect that the copy number of a gene will be similar to the copy number
of its closest neighbors, with that expected similarity decreasing when genes are further apart.
Finally, for a given copy number, the aCGH fluorescence ratios should be centered around a log2
value, with some random noise. We want to use the observed log-ratios to identify regions with
altered copy number. The biological features of this model (a finite number of unknown or hidden
states that are indirectly measured, with states of close elements likely to be similar, and variable
distances between genes) can be modelled with a non-homogeneous Hidden Markov Model (HMM)
[CMR05]. To provide a direct estimate of the probability that a given gene or region has an altered
copy number we will use a Bayesian model computed via Markov Chain Monte Carlo (MCMC).
Since we do not know the true number of hidden states, we fit models with varying number of
hidden states and, to allow for transdimensional moves between models with different numbers of
states, we use Reversible Jump [Gre95]. After running a large number of MCMC iterations, we can
summarize the posterior probabilities. First, we will obtain posterior probabilities for the number
of states. Conditional on a given number of states, each model will provide posterior distributions
of the parameters of interest (e.g., means, variances, transition matrices). From the later, we
can obtain posterior probabilities that a gene is gained or lost. To obtain our final estimates,
we incorporate the uncertainty in model selection by using Bayesian Model Averaging [HMRV99]
(estimates are weighted by posterior probability of each number of states), for the probabilities of
genes being gained or lost. The complete statistical method we will call RJaCGH (from Reversible
Jump-based analysis of array CGH).
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25 %

50 %

65 %

Proportion of genes missing

Figure 1: Correct classification: effects of variability in inter-gene distance (percentage of genes
missing). Shown are the mean and 95% confidence interval around the mean of the correct classification error rate. Each mean and confidence interval is computed from 500 data sets [WF05]
(see text and Supplementary material for generation of inter-gene distance variability).
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Results and discussion

We have applied RJaCGH and several alternative methods (including the best-performing ones
[WF05, LJKP05]) to 500 simulated data sets [WF05] (see Supplementary material simulations).
These are data “(...) simulated to emulate the complexity of real tumor profiles” and designed to
become “(...) a standard for systematic comparisons of computational segmentation approaches”
[WF05]. To assess the effect of variable inter-gene distance, we randomly deleted data points (see
details in supplementary material) so that each original simulated data set gives rise to another
four data sets with (an average of) 10%, 25%, 50% and 65% of observations missing; the length of
these gaps is modeled by a Poisson distribution, so larger percentages of missing data correspond
to larger variability in inter-gene distances. Results in Figure 1 (see also Supplementary material
Figure 1) show the excellent performance of RJaCGH, and how it outperforms alternative methods.
Moreover, Figure 2 (see also Supplementary material Figures 2 and 3) shows that the difference
between RJaCGH and alternative approaches is accentuated when we consider jointly the effects of
noise and variability in inter-gene distance. Analysis using three other performance statistics (False
Discovery Rate, Sensitivity, and Specificity) show the same overall patterns (see Supplementary
material, Figures 2 and 3): for some specific statistics, RJaCGH can be second (but very close)
to another approach; this other approach, however, performs poorly with respect to the remaining
statistics. Similar results are obtained when applying these methods to a real data set of nine
cell lines [SNS+ 01], and comparing the predicted ploidy with the known ploidy [SNS+ 01] (see
Supplementary Material, Figure 4). Overall, therefore, RJaCGH is the best performing method
when considering the four available statistics.
As RJaCGH provides posterior probabilities of alteration of contiguous genes (segments), it is
relevant for recent efforts in aCGH methodology [RSH+ 06, DEG+ 06]. We can use the probabilities
to identify regions with consistent alterations across samples (in a statistically rigorous way, including control of False Discovery Rate), and detect subgroups of samples according to recurrence
patterns. Likewise, posterior probabilities of being in a specific state can be used as the basis for
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Figure 2: Correct classification: joint effects of noise and variability in inter-gene distance. Same
data as in Figure 1. The noise (standard deviation) of each sample is split into ten non-overlapping
ranges, and each panel shows the mean correct classification success vs. the proportion of missing
genes (i.e., increasing levels of variance in inter-gene distance); each mean is based on approximately
50 samples.
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identifying breakpoints of biological significance. Finally, the model of RJaCGH can be extended
to provide a rigorous downstream analysis of aCGH including the integration of gene expression
and proteomic data [PSP+ 02, WF05].

4
4.1

Methods
Model

We use a non-homogeneous Hidden Markov Model with Gaussian emissions. We can either fit one
model to all the chromosomes of an array or we can fit a different model for each chromosome
of an array. Let n be the number of genes, and k the number of different copy numbers in the
collection of genes. Let Si be the true state (copy number) of the gene i: Si = {1, . . . k}i=1,...,n .
Let Yi be the relative copy number of the gene i, that is the log ratio of fluorescence intensities
between tumor and control samples. Let Xi be the distance in bases between gene i and gene i + 1
(we normalize these distances between 0 and 1 to increase numerical stability). How distance is
measured depends on the platform: distance can be the distance from the end of the spot to the
start of the next, if the length of the spots is proportional to the length of the gene (so we have the
same information for every gene), or the distance between the midpoint of the spots, if the length
of the spots is not proportional to the length of the gene.
We assume that {Si } follows a non-homogeneous 1st order Markov process, as: P (Si =
si |Si−1 = si−1 , Xi−1 = xi−1 ) = Qsi−1 ,si ,xi−1 . Biologically, we expect that QSi−1 =r,Si =r,Xi−1 ,
the probability of staying in the same hidden state, is a decreasing function of Xi−1 , so the dependence of the state of a gene onto the next one is lower the further the genes are. We also expect
that when the distance between two genes is maximal, the state of a gene should be independent
from the state of its predecessor. Thus, we model the transition probabilities as:

Where β has the form:

exp{−βi,j + βi,j x}
Qi,j,x = Pk
p=1 exp{−βi,p + βi,p x}


0

 β2,1

β= .
 ..
βk,1

β1,2
0
..
.
βk,2

. . . β1,k
. . . β2,k
..
..
.
.
...
0







(1)

(2)

With all βi,j ≥ 0 ∀i, j. Finally, conditioned on {Si }, {Yi } follows a Gaussian process: (Yi |Si =
si ) ∼ N (µsi , σs2i ).
For computational reasons and modeling flexibility, we opted for Bayesian methods using
Markov Chain Monte Carlo. To fit models with varying number of hidden states we use Reversible Jump. Suppose that we have a collection of K HMM models, and each of them has a
number of k hidden states, from k = {1, . . . , K}. Let θ(k) be the HMM associated to k, that is
θ(k) = {µ(k), σ 2 (k), β(k)}. The prior distributions for the model are the usual ones in mixture
problems [RG97]: p(k) is the prior for the number of hidden states with p(k) ∼ U (1, k), p(θ(k)/k) is
the prior of the HMM conditioned to k, the number of hidden states with µ(k) ∼ N (α, ̺2 ), where
α and ̺ are the median and range of Yi ; σ 2 (k) ∼ IG(ka, g), where ka is 2 and g is ̺2 (Yi )/50;
β(k) ∼ Γ(1, 1). The likelihood of the model, L(y; k, θ(k)), can be computed by Forward Filtering
[CMR05], so the joint distribution is p(k)p(θ(k)/k)L(y; k, θ(k)).

4.2

Estimation and fitting

We can draw samples from the posterior distribution through a Reversible Jump Markov Chain
Monte Carlo (RJMCMC) algorithm [Gre95]. In RJMCMC, we explore the posterior distribution of
possible models, jumping not only within a model but also between models with a different number
of parameters. To match the difference between degrees of freedom, some random numbers u with
density P (u) are generated, so if we are in state x, the new one is proposed in a deterministic
way x′ (x, u). The reverse move is the inverse of that function: x(x′ , u′ ). This way, the usual
Metropolis-Hastings acceptance probability can be computed [RG97]:


L(y/x)p(x′ )p(u′ /x′ )
|J|
(3)
min 1,
L(y/x)p(x)p(u/x)
5
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where L(y/x) is the likelihood, p(x) are the priors, p(u/x) are the densities of the candidates,
∂x′
and J = | ∂(x,u)
|, the determinant of the Jacobian of the change of variable. We combine several
Metropolis steps in a sweep [CMR05, RRT00]:
1. Update HMM of a model using a series of Metropolis-Hastings moves. (We do not use Gibbs
Sampler to avoid the hidden state sequence from becoming part of the state space of the
sampler, so dimensionality is reduced and reaching convergence is easier).
2. Update model (birth/death). When we have r states, a birth/death move is chosen with
probabilities pbirth (r) and pdeath (r) (these are 1/2 except in the cases when no movement of
that type can be made, e.g. a death move when there is only one state). If a birth move is
selected a new one is created from the prior distributions and accepted with probability:


L(y; r + 1, θ(r + 1))p(k = r + 1)pdeath (r + 1)
|Jbirth |
min 1,
L(y; r, θ(r))p(k = r)pbirth (r)
and Jbirth = 1

(4)

If a death move is chosen, a random state is deleted with a probability inverse to eq.[4].
3. Update model (split/combine). A split/combine move is attempted with probabilities psplit (r)
and pcombine (r) (again, 1/2 except when a move can not be made). If a split move is selected,
an existing state i0 is split into two, i1 , i2 :
µi1 = µi0 − ǫµ ,

µi2 = µi0 + ǫµ ,

ǫµ ∼ N (0, τµ )

(5)

σi21 = σi20 ǫσ ,

σi22 = σi20 (1 − ǫσ ),

ǫσ ∼ β(2, 2)

(6)

i0 :

βi,i1 = βi,i0 ǫβ ,

Split column
βi,i2 = βi,i0 /ǫβ ,

ǫβ ∼ LN (0, τβ )

for i 6= i0

(7)

Split row
i0 :

βi1 ,j = βi0 ,j Uj , βi2 ,j = βi0 ,j (1 − Uj ),
where Uj ∼ β(2, 2) for j 6= i0
βi1 ,i2 ∼ Γ(1, 1)

(8)

This move is accepted with probability
min{1, p} where
L(y; r + 1, θ(r + 1))(r + 1)P (k = r + 1)P (θ(r + 1))Pcombine (r + 1)r
p=
L(y; r, θ(r))P (k = r)P (θ(r))Psplit (r)(r + 1)
1
Q
Q
|Jsplit |
×
2P (ǫµ )P (ǫσ ) P (ǫβ ) P (Uj )
Y
Y βi,i
0
and |Jsplit | = |2r σi20
βi0 ,j
|
ǫβ
j6=i0

i6=i0

(9)
The split move must follow the adjacency condition [RG97] (the resulting states must be
closer between them than to any other of the existing ones). If a combine step is selected,
the symmetric move is performed and the inverse probability of acceptance is computed.
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The combination of birth and split moves makes it possible not only to visit models with
different number of parameters, but also to explore more thoroughly the posterior probability in
the case of a parameter with a multi-modal density.
These moves are common ones [CMR05, RRT00], but we have changed several aspects of their
design to improve the probability of acceptance, which is the most difficult step in Reversible Jump
[CMR05, Gre95, RRT00]. We constraint the variance of every state so that it can not be greater
than the variance of the whole data. Also, we have added the adjacency condition mentioned
before, and used centering proposals. To prevent label-switching of states we have ordered the
states according to means after every iteration of the sweep [RG97].

4.3

Inference

We run the former algorithm a large number of times (e.g., 50000) and, after discarding the
first iterations as burn-in, we keep the last (e.g., 10000) samples as observations from the joint
distribution, so we can make inferences from it. For every model that has been visited we obtain
the posterior probabilities of the mean copy number of every state, the variance of the copy number
of every state, and the function of transitions between hidden states. By counting the number of
times that each model has been visited we obtain an estimate of the posterior probability of each
model (i.e., we avoid using BIC or AIC). Then, applying the Viterbi algorithm [CMR05] to every
sample obtained from the MCMC, and as this sample is a function of the HMM, we can obtain
its posterior probability, something that usual Viterbi can not. From the Viterbi paths for all the
samples, we can then compute the posterior probability that a gene belongs to every state or the
probability that a sequence of genes is in a given state.
When obtaining posterior probabilities of copy number change, we use Bayesian Model Averaging [HMRV99] over all models visited. Let Si be the lost, gained, no-change status of gene i,
K the set of the models considered (in our case, that would be HMMs with 1, . . . , K number of
states), Mk the model with k number of states and Si /Mk the state of gene i according to model
k. We compute the unconditional (with respect to model selection) probability for the gene i as:
X
p(Si = si |y) =
p(Mk |y)p(Si = si |Mk , y)
(10)
k∈K

When analyzing multiple arrays, it is straightforward to use our approach to identify genes that
show consistent copy
alterations across samples as
P number
P
p(Si = si |y) = N
p(M
k |yj )p(Si = si |Mk , yj )p(yj ) where yj are the data from array j
j=1
k∈K
and we have N arrays. If we have information about the reliability/representativeness of an array,
that can be incorporated via p(yj ); otherwise we set p(yj ) = 1/N .

4.4

Checking convergence and influence of priors

As in any MCMC approach, it is crucial to assess convergence of the sampler. We follow common
practice [BG98] of running several chains in parallel. The convergence of the sampler depends
strongly on the distribution of the candidates in Metropolis-Hastings. That is, every iteration
a new value for the parameters is proposed from a distribution centered in their current values.
The standard deviation of that distribution must be chosen in a way that samples explore all
the parameter space. These standard deviations are not parameters of the model in the sense
that different values give different fits, but values that can speed up convergence of the algorithm.
The convergence of the posterior probability of the number of hidden states is reached when a
large enough number of transdimensional moves is made. This number need not to be large if the
likelihood is substantially higher in a particular model and data size is big enough. The birth and
death moves only depend on the priors, but the split and combine moves depend also on their own
design and the values of τµ and τβ (see eq. [5] and eq. [7]). The priors chosen have been extensibly
tested in mixture models [RG97]. In addition, the priors and rest of the parameters have very little
effects: even small CGH arrays contain thousands of points so that the likelihood from the data
dominates any prior. With the 2500 simulated data sets analyzed, we have only needed to specify
the number of burn-in —50000— and to-keep samples —10000— and the number of chains —4—
and only in 9 cases was there evidence of non-convergence —which was solved by re-running the
samplers again.

7
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4.5

Implementation and analysis

We have implemented RJaCGH using C (for the sweep algorithm) and R [R D06], and all analysis
and comparisons have been done in R. See Supplementary Material.

5

Supplementary material

The supplementary material is available from http://ligarto.org/rdiaz/Papers/rjhmm-supp-mat.
pdf.
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1
1.1

Method comparisons: general
Methods compared

We have examined the performance of our method and compared it two four other methods: DNA
copy [1] and ACE [2], two competing approaches that have been shown to be among the best
performers in recent reviews [3, 4], and the HMM [5] and non-homogeneous HMM [6] approaches,
two methods that share some common features with our method (but see discussion). All of these
approaches, except ACE, are available as R/BioConductor packages. ACE is available as a Java
program from [2]; however, this Java program is not suitable for batch processing of simulations;
thus, we implemented it as a loadable C module, and call it from R. Other promising methods
(specially [7]) could not be included in the comparative study because code is not available or
directly implementable from the available published descriptions.

1.2

Settings of methods

All methods were run with their default parameters. Details and modifications follow.
For DNA copy, and following the recommendations in [3], we have used the “merge levels”
proposal of [3]. The methods of Fridlyand et al. [5] and Marioni et al. [6] include an internal,
implicit, merge levels-like algorithm.
For ACE [2] the FDR used is the minimal one of the available (experimenting with the method
in these data set showed that other, larger, FDRs lead to much poorer performance).
RJaCGH was run with six parallel chains, each with 60000 iterations of which the first 50000
were discarded as burn-in. For each run, two full chains were discarded by trimming (i.e., eliminating the two most extreme observations, one on each tail, with respect to the average estimated
number of states of each chain). The parameters of the distributions of the candidates were selected
automatically by a heuristic approach that, within model, leads to an acceptance probability near
0.23 [8]. The parameters of the jumps between models were taken as the mean of the within model
parameters.

1.3

Mapping of methods’ output to gain/loss/no-change

Only ACE provides, directly, output labels that correspond to “gain/loss/no change” status of the
genes. For DNAcopy, and as in [3], we post-processed the merge levels output, so the level with
mean closest to zero, which is also the level with the largest number of observations, was assigned
to the “no change” class (which is consistent with all assumptions in the normalization step, and
most in the analysis step, that most genes/clones are not affected by copy number changes). The
remaining levels were assigned to either “gain” or ”lost” depending on whether there smoothed value
was larger or smaller, respectively, than the “no change” class. Similar procedure was followed with
HMM and BIOHMM after these methods returned their output.
For RJaCGH, our method includes a some what similar approach. We consider as “no change”
all states whose IQR (interquartile range) includes 0. After this step, we add the groups with
posterior mean closes to 0 to the “no change” class until the proportion of observations in the no
change class is no less than a pre-specified level (by default 0.65). This procedure is consistent with
the assumptions in the normalization step that most genes/clones are not affected by copy number
changes.

1.4

Statistics used to evaluate performance

We have evaluated performance of each method using four different statistics. To understand the
statistics, it is useful to refer to table 1.
Correct classification rate The percentage of genes that are assigned to the right class. In table
1, the sum of all diagonal terms divided by the total number of clones. This is an overall
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Table 1: Confusion matrix

Gained
No change
Lost

True
State

Gained
TG
N Cg
Lg

Predicted
No change
Gnc
TNC
Lnc

Lost
Gl
N Cl
TL

estimate of how well a method is doing. This is likely to be the most relevant measure in
every day usage, as it combines the measures below (and incorporates, for instance, trade-offs
between False Discovery Rate and Sensitivity).
False Discovery Rate We define it in here as the number or mistakes made when we call something a gain or a loss: the number of no-changes among the clones Predicted to be gains or
losses. In the table above,
F DR =

N Cg +N Cl
T G+N Cg +Lg +Gl +N Cl +T L

(i.e., the sum of N Cg and N Cl divided by the total number of those predicted to be “gained”
or “lost”). (Note that, in our comparisons, there was not a single case, for any method, were
a true gain was predicted to be a lost, or vice-versa).
Specificity The probability of predicting no change when the true state is no change. In terms of
table 1:
Specif icity =

T NC
N Cg +T N C+N Cl

Sensitivity The probability of predicting a gain (loss) outcome when the true state is gained (lost).
Here we sum over both possible deviations from no change:
Sensitivity =

T G+T L
T G+Gnc +Gl +Lg +Lnc +T L

It should be noted that there are ways to achieve, e.g., great False Discovery Rate, without
being a good overall performer. For instance, by requiring very strong evidence to call something
a loss, we can reduce the False Discovery Rate, at the expense of not identifying many changes
as such (i.e., at the expense of lowering the sensitivity). Similarly, if a method predicts no change
most of the time, the Specificity will be high at the expense of a low sensitivity.

2
2.1

Simulations
Simulation settings

We have used the same simulated data sets as Willenbrock and Fridlyand [3] used in their recent
comparison of methods of aCGH analysis [3]. Details of the data are provided in the original
paper [3]; briefly, these are data “(...) simulated to emulate the complexity of real tumor profiles”
and designed to become “(...) a standard for systematic comparisons of computational segmentation
approaches” [3, p. 4]. The authors simulated five hundred data sets based on the profiles of real
tumor samples, and a sample-specific variance (between 0.1 and 0.2) was added to each sample.
It is unlikely that these data were simulated under a model that is specifically well suited for our
method. Other simulated data sets (or simulation approaches) did not seem appropriate to compare
alternative approaches; most papers that present simulated data do simulate the data under models
that are the same (or very similar to) the model used to analyze the data. The simulations in [1]
are useful for examining breakpoint detection, but not for questions related to the recovery of the
correct “gained, lost, no change” label, and the simulations in [4] are too simplistic in their settings
3
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(only a single type of alteration added) and the number of points generated is too short (100). The
500 data sets of Willenbrock and Fridlyand [3], however, are suitable for examining recovery of true
labels, are simulated based on real profiles to which varying levels of noise are added, and provide a
sufficiently large and diverse data set to gain valuable information about the relative performance
of different methods.
We downloaded the data [3] from http://www.cbs.dtu.dk/~hanni/aCGH/, and the actual file
used was
http://www.cbs.dtu.dk/~hanni/aCGH/20chromosome.simulated.data.RData.
Each of the 500 simulations consisted of 20 chromosomes, with 100 clones in each chromosome.
One hundred clones per chromosome are too few points (at least for most aCGH data for human
samples) and make it hard to assess the effect of differences in spacing between clones. Thus, instead
of using the 2000 clones as if divided in 20 chromosomes, we just regarded all the 2000 clones as if
they came from the very same single chromosome which allows us to introduce fairly large numbers
of missing data (i.e., variability in spacing).
None of the data sets above included variability in inter-gene distances which, as we argue in
the paper, is an important feature of many real aCGH data sets, and a specific problem we try to
address with our method. Therefore, to assess if our method does perform reasonably under varying
inter-gene distance (and how it performs compared to other methods) we need to add inter-gene
distance to the data set. Instead of modifying the original simulation models of [3], we have instead
introduced “holes” (or missings) in the data thus replicating a situation where the data are generated
according to the models in [3], but the actual observed data is a sample from the generated data
(such as is the case with many aCGH platforms that show unequal coverage of different parts of
the genome).
The “holes” or missing fragments in the data have been created with a very simple model:
we choose at random 100 locations in the genome, and eliminate a contiguous segment of clones.
The length of this segment is modeled with a Poisson distribution (so the actual length of the
segment that is missing is drawn, randomly, from a Poisson distribution with parameter λ). This
λ parameter determines the average number of missing points; in addition, as this is a Poisson
distribution (where the variance is = λ), increasing λ results in an increase in the variance of the
length of the missing fragments. We have used, for the λ parameter, the values 2, 5, 10, or 13.
Thus, for each original data set, we obtain another four data sets, with a different number of missing
data points. On average, the derived data sets have 10%, 25%, 50% and 65%. In other words, from
the 500 data sets, we generate another 2000 data sets. Thus, of the 2500 data sets, each subset
of 500 has an average number of missing points of 0% (in this case, 0 is not an average, but the
actual number), 10%, 25%, 50% and 65%. To minimize the variability in methods’ comparisons,
the derived data sets analyzed by all methods were the same.

2.2

Results and discussion

Results are shown in Figures 1, 2, 3.
Overall performance: Correct Classification Rate RJaCGH is better than any of the alternative approaches:
• The difference in performance between RJaCGH and alternative approaches increases
as the variability in spacing between clones increases (i.e., as the proportion of missing
genes increases). These patterns are seen in Figure 1 (a).
• The difference between RJaCGH and alternative approaches, is accentuated in Figures
2 and Figure 3: contrary to other methods, RJaCGH does not suffer the same decrease
in performance as the noise in the data increases.
False Discovery Rate The best performer is DNAcopy, and RJaCGH is the second best; all other
methods suffer from much greater False Discovery Rates (Figure 1, (b)). As the noise in the
data increases, however, the difference between RJaCGH and DNAcopy becomes smaller with
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Figure 1: Comparative performance on the simulated data from [3] (see text for details). Relationship
between the average value of the statistic and the variability in inter-gene distance (increases in the percentage of genes missing are directly related to increases in the variability in inter-gene distance). Shown
are the mean and 95% confidence interval around the mean (based on 500 data sets). In panels (a), (c),
(d), higher is better; in panel (b) lower is better.
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RJaCGH being the method with smallest FDR at the highest noise levels (Figure 3 (b)). For
all practical usages, however, differences between RJaCGH and DNAcopy in terms of FDR
are probably negligible.
Note, however, that the good performance of DNAcopy with respect to False Discovery Rate
is at the expense of a reduced Sensitivity (see next).
Sensitivity The largest sensitivity is achieved by BIOHMM at small values of noise in the data
and by RJaCGH with higher noise levels (see panel (c) in all Figures). Over all levels of noise
in the data, however, the performance between RJaCGH and BIOHMM (Figure 1 (c)) is
indistinguishable, but clearly superior to other methods. The good performance of BIOHMM
with respect to Sensitivity, however, is achieved at the expense of its high False Discovery
Rate and low Specificity (see below).
Specificity As could be expected from the definition of Specificity and False Discovery Rate, the
patterns of Specificity are similar to those commented above for False Discovery Rate.
In summary, RJaCGH has the largest correct classification. For some specific statistics, RJaCGH
can be second (but very close) to some approaches; these other approaches, however, perform poorly
in the other performance statistics. Overall, therefore, RJaCGH is the best performing method when
considering the four available statistics.
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Figure 2: Analysis of simulated data: conditioning on variability of inter-gene distance. Analysis of data from Willenbrock and Fridlyand [3] (see text for details
on addition of gaps). For each level of average number of missing genes (0, 10, 25, 50, 65 %) or, equivalently, for increasing levels of variance in the distance
between clones, we compute the mean of the statistic at ten equally spaced levels of noise in the data (i.e., the 500 data sets have been divided in 10 groups
according to their noise, so that the midpoints of each interval are 0.105, 0.115, 0.125, . . . , 0.185, 0.195). Therefore, each point in the figure corresponds to the
mean from about 50 samples.
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Figure 3: Analysis of simulated data: conditioning on sample noise. Analysis of data from Willenbrock and Fridlyand [3] (see text and Figure 2 for details).
The noise (standard deviation) of each sample is split into ten non-overlapping ranges, and each panel shows the average value of the statistic vs. the proportion
of missing genes (i.e., increasing levels of variance in inter-gene distance) for a given sample noise.
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Figure 4: Comparative performance on the nine cell lines from Snijders et al. [9]. We show the value of
the performance statistics for each cell line (numbered 1 to 9, which correspond to gm01524, gm01535,
gm01750, gm03134, gm03563, gm05296, gm07081, gm13031,gm13330, respectively). In all these figures,
“larger is better” (note we use 1- FDR, not FDR). Only three values are shown for BIOHMM, as the rest
of data lead to crashes in the program.

3

Real data from Snijders et al.

We have also analyzed the well known nine cell lines from Snijders et al. [9] available from
http://www.nature.com/ng/journal/v29/n3/suppinfo/ng754 S1.html and we have compared the
results from our method with the known ploidy, as provided by Snijders et al.
Figure 4 shows the comparative performance of each of the methods. From the figure we see
that RJaCGH has performance comparable to that of the best method for each statistic.
As an example of the type of output provided by RJaCGH, Figure 5 shows the results of one
analysis for the complete genome of the cell line gm03563. Panel a) indicates a large posterior
probability of a model with four hidden states; two of the states of the four-state model, however,
are extremely close to each other (panel b) and, because of their posterior means (panel b) and
variances (panel c) we consider them to represent the same biological state of no change in copy
number. The other two states are well separated, with posterior means clearly negative or positive,
so we regard them as biological states of loss and gain of copy number. Note that the component
that represents the hidden state of loss is assigned to only two genes (panel e, green dots), exactly the
same two genes whose true state is loss [9]. Panel d) shows that the probability of remaining on the
same state decreases as distance increases, eventually becoming 0.25(= 1/Number hidden states).
Finally, panel e) shows the results from the Bayesian Model Averaging. This is a particularly clearcut model, as the posterior probabilities that each gene belongs to the state with highest posterior
is very high (the lower blue line is > 0.9 for almost all genes).

4

Implementation and analysis

We have implemented RJaCGH using C (for the sweep algorithm) and R [10]. The code is available
from CRAN
9
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Figure 5: Results of the RJaCGH analysis of gm03563 cell line from Snijders. Results shown are from
four parallel chains; see text for details about other parameters. The lower panel shows the results from
the Bayesian Model Averaging step (see text); black dots correspond to genes classified as ’normal’ or
non-changed, red dots to genes classified as ’gained’ and green dots to genes classified as ’losses’; the lower
blue line shows the posterior probability for every gene of belonging to the predicted state. The vertical
alternating white and grey bars denote the different chromosomes with the chromosome number shown at
bottom.

(http://cran.r-project.org/src/contrib/Descriptions/RJaCGH.html)
and from the Asterias site (http://www.asterias.info). All analysis and comparisons have been
done in R, using the BioConductor (http://www.bioconductor.org) packages DNAcopy by by E.
S. Venkatraman and Adam Olshen and aCGH by Jane Fridlyand and Peter Dimitorv, and a version
of ACE implemented by O.M.R. in R and C.
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